Abeona Therapeutics (ABEO) EBIT (2011 - 2026)
Abeona Therapeutics (ABEO) posted quarterly EBIT of -$23.0 million for Q1 2026, down 16.76% year-over-year from -$27.7 million in Q1 2025, and down 0.53% quarter-over-quarter from -$22.9 million in Q4 2025.
Abeona Therapeutics (ABEO) EBIT (2011 - 2026) Analysis & Trends
Abeona Therapeutics' EBIT history runs 16 years deep, the most recent figure standing at -$23.0 million for Q1 2026.
- In Q1 2026, EBIT fell 16.76% year-over-year to -$23.0 million; the TTM figure through Mar 2026 stood at -$92.8 million (down 33.25% YoY), while the FY2025 annual figure was -$89.4 million, down 39.3% from the prior year.
- EBIT for Q1 2026 stood at -$23.0 million, down from -$22.9 million in the prior quarter.
- The five-year high for EBIT was -$8.0 million in Q2 2022, with the low at -$24.0 million in Q3 2025.
- The 5-year median for EBIT is -$15.3 million (2024), against an average of -$16.2 million.
- The sharpest annual moves came in 2022 and 2024: EBIT soared 72.27% in 2022, then slumped 69.26% in 2024.
- Abeona Therapeutics' EBIT stood at -$12.9 million in 2022, then dropped by 2.11% to -$13.2 million in 2023, then dropped by 26.22% to -$16.7 million in 2024, then slumped by 37.42% to -$22.9 million in 2025, then decreased by 0.53% to -$23.0 million in 2026.
- Business Quant data shows ABEO's EBIT at -$23.0 million in Q1 2026, -$22.9 million in Q4 2025, and -$24.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -3,158.03 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | -13.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.65 Mn |
| Mar 31, 2026 | -23.03 Mn |
| Dec 31, 2025 | -22.91 Mn |
| Sep 30, 2025 | -24.02 Mn |
| Jun 30, 2025 | -22.79 Mn |
| Mar 31, 2025 | -19.73 Mn |
| Dec 31, 2024 | -16.67 Mn |
| Sep 30, 2024 | -15.35 Mn |
| Jun 30, 2024 | -17.86 Mn |
| Mar 31, 2024 | -14.33 Mn |
| Dec 31, 2023 | -13.21 Mn |
| Sep 30, 2023 | -11.33 Mn |
| Jun 30, 2023 | -10.55 Mn |
| Mar 31, 2023 | -12.04 Mn |
| Dec 31, 2022 | -12.94 Mn |
| Sep 30, 2022 | -9.38 Mn |
| Jun 30, 2022 | -8.01 Mn |
| Mar 31, 2022 | -20.59 Mn |
| Dec 31, 2021 | -46.65 Mn |
| Sep 30, 2021 | -14.87 Mn |